Dr. Erik Årstad
Erik
Årstad, Ph.D. is
Senior Lecturer in Radiochemistry at the University College London.
Erik coauthored
Positron emission tomography imaging of drug-induced tumor apoptosis
with a caspase-3/7 specific [18F]-labeled isatin
sulfonamide,
[18F]Fluoromethyl-[1,2-2H4]-choline:
A novel radiotracer for imaging
choline metabolism in tumors by positron emission tomography,
Relationship between ketamine-induced psychotic symptoms and NMDA
receptor occupancy — a [123I]CNS-1261 SPET
study,
ROMPgel-supported tris(triphenylphosphine)rhodium(I) chloride: a
selective hydrogenation catalyst for parallel synthesis, and
Towards NR2B receptor selective imaging agents for PET
— synthesis and
evaluation of N-[11C]-(2-methoxy)benzyl (E)-styrene-,
2-naphthyl- and
4-trifluoromethoxyphenylamidine.
Read the
full list of his publications!
Erik earned his Ph.D. in Radiochemistry at the University of Oslo,
Norway in 2001.
He holds patent
Selective radiolabeling of biomolecules and patent applications
Radiofluorination and
Radiolabelling methods.
Read
Biological fate of nanoparticles in the body.
Read his
ResearchGate profile.
